December 12, 2025

Antibody formulation could enable simple injections instead of lengthy hospital infusions

December 12, 2025 / Research update / InnovateMed Author / antibody

by Anne Trafton, Massachusetts Institute of Technology edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The advance represents a major step toward re-formulating antibodies so that they can be injected using a standard syringe. Credit: Christine Daniloff, MIT; microparticles courtesy of the researchers Antibody treatments for cancer and other diseases are typically delivered intravenously, because of […]

Antibody formulation could enable simple injections instead of lengthy hospital infusions Read More »

Reproduced human neural circuits show the crucial role of the thalamus in shaping the cortical circuit

December 12, 2025 / Research update / InnovateMed Author / cortical unit

This discovery may pave the way for developing new medications to treat neurodevelopmental disorders. Peer-Reviewed Publication Nagoya University image: Assembloid [3D fluorescent staining] Axons in the thalamus (pink) extended toward the cortex, while those in the cortex (green) extended toward the thalamus at 14 days post-fusion. view more Credit: Fumitaka Osakada A Japanese research team has

Reproduced human neural circuits show the crucial role of the thalamus in shaping the cortical circuit Read More »

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

December 12, 2025 / Research update / InnovateMed Author / chromatin

Researchers uncover how altered chromatin accessibility reprograms stem cells and fuels disease progression in myelodysplastic syndrome Peer-Reviewed Publication The Institute of Medical Science, The University of Tokyo image: Genome-wide chromatin accessibility profiling reveals how myelodysplastic syndrome (MDS) stem cells progressively lose normal stem-cell features and acquire myeloid progenitor-like characteristics. These chromatin shifts help map the

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression Read More »

Vaccines do not cause autism: WHO

December 12, 2025 / Patient education / InnovateMed Author / autism

edited by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain A new analysis by the World Health Organization reaffirmed there is no link between vaccines and autism—contrary to theories being propagated in the United States. The US Centers for Disease Control and Prevention (CDC) last month revised its website with language that undermines its previous, scientifically-grounded

Vaccines do not cause autism: WHO Read More »

Plasma p-tau217 can reliably detect preclinical Alzheimer disease

December 12, 2025 / Research update / InnovateMed Author / alzheimer

by Lori Solomon edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes Plasma phosphorylated tau 217 (p-tau217) can reliably detect Alzheimer disease (AD) pathology in the preclinical stage, according to a meta-analysis published online Dec. 1 in JAMA Neurology. Michael Malek-Ahmadi, Ph.D., from the University of Arizona College of Medicine-Phoenix, and colleagues conducted a systematic literature review to identify

Plasma p-tau217 can reliably detect preclinical Alzheimer disease Read More »

Clinicians now have powerful new tools to diagnose multiple sclerosis earlier

December 12, 2025 / Clinical Practice / InnovateMed Author / multiple sclerosis

by Ellen Goldbaum, University at Buffalo edited by Gaby Clark, reviewed by Robert Egan Editors’ notes This image of the brain of a 45-year-old female with secondary-progressive MS indicates with a white arrow the presence of a paramagnetic rim lesion. The image was obtained using Quantitative Susceptibility Mapping (QSM), an advanced MRI technique that can detect these lesions. Credit: University

Clinicians now have powerful new tools to diagnose multiple sclerosis earlier Read More »

How you eat may be connected to how you sleep

December 12, 2025 / Patient education / InnovateMed Author / sleep

by George Mason University edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain The average adult should get a minimum of seven hours of sleep daily, according to Centers for Disease Control and Prevention recommendations. However, an estimated 50 to 70 million Americans are diagnosed with a sleep disorder (such as sleep apnea

How you eat may be connected to how you sleep Read More »

Psoriasis study shows link between fat metabolism and skin inflammation for first time

December 12, 2025 / Research update / InnovateMed Author / psoriasis

by Medical University of Vienna edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Representative images of H&E staining of back skin (left) and histological quantification of the dermal white adipose tissue (DWAT) area (right). Credit: Cell Death & Differentiation (2025). DOI: 10.1038/s41418-025-01630-4 A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered

Psoriasis study shows link between fat metabolism and skin inflammation for first time Read More »

Scientists uncover key driver of treatment-resistant cancer: Genome-scrambling enzyme points to new treatments

December 12, 2025 / Research update / InnovateMed Author / cancer

by University of California – San Diego edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes These images show the beginnings of chromothripsis in colorectal cancer cells. The N4BP2 enzyme (green) infiltrates a micronucleus (zoomed in square selections), where it induces DNA damage (red). Blue represents the main cell nucleus. Credit: UC San Diego Health Sciences University

Scientists uncover key driver of treatment-resistant cancer: Genome-scrambling enzyme points to new treatments Read More »

How CAR T-cell therapies target myeloma at the molecular level

December 12, 2025 / Research update / InnovateMed Author / myeloma

by Anne Grimm, Leipzig University edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Graphical abstract. Credit: Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.10.014 In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR T-cell therapy may be considered. In this innovative

How CAR T-cell therapies target myeloma at the molecular level Read More »